PTCH1 and adrenal cortex carcinoma: We previously showed that Ptch1 drug efflux inhibition enhanced the cytotoxicity of dxr against adrenocortical carcinoma cells, but also that of cisplatin, another well known chemotherapeutic drug [19], suggesting that both cisplatin and dxr are substrates of Ptch1 [16].